Nstemi - Non-St Segment Elevation Mi Clinical Trials
2 recruiting trials for Nstemi - Non-St Segment Elevation Mi. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Nstemi - Non-St Segment Elevation Mi clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by University Hospital, Basel, Switzerland (1), Montreal Heart Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Machine learning based development of a diagnostic tool for acute cardiovascular disease (other, 1 trial), followed by Ticagrelor + placebo, Ticagrelor + aspirin.
Track Nstemi - Non-St Segment Elevation Mi trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions
The research project aims to develop clinical decision support tools integrating established diagnostic variables and machine learning (ML) models for rapid diagnosis of acute...
Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
In patients with a myocardial infarction (MI) treated medically alone, the objective of the PANTHEON trial is to evaluate if ticagrelor monotherapy reduces bleeding events,...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Nstemi - Non-St Segment Elevation Mi, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Nstemi - Non-St Segment Elevation Mi, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Nstemi - Non-St Segment Elevation Mi, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.